NED Medical has filed a notice of an exempt offering of securities to raise $1,800,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NED Medical is raising $1,800,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Richard Yazbeck played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About NED Medical
The technology we are developing at NED Medical will transform oncology embolization from a palliative to a curative treatment while dramatically reducing or eliminating the debilitating side effects and toxicities common with todays therapies. This will revolutionize the treatment of patients with unresectable tumors.
To learn more about NED Medical, visit http://www.nedmedical.com/
Contact:
Richard Yazbeck, President and Chief Executive Officer
408-731-0344
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.